What is DXR's health score?

As of October 31, 2026, TradeApes rates DAXOR CORP (DXR) 27 out of 100 (Stressed); valuation verdict: Inconclusive. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DXR's estimated fair value?

Our methods couldn't reach a reliable fair value for DXR yet. This is a model assessment, not a price target or investment recommendation.

Is DXR undervalued or overvalued?

Our model currently rates DXR as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

📱 Now on iPhone — live scores, valuations & alerts on the go

Download iPhone App

DAXOR CORP (DXR)

Name: TradeApes health score and valuation for DAXOR CORP (DXR)
Creator: TradeApes
License: https://www.tradeapes.com/terms.html

Inconclusive inconclusive stressed

$9.2

Updated: 2026-10-31

As of October 31, 2026, TradeApes rates DAXOR CORP (DXR) 27 out of 100 (Stressed); valuation verdict: Inconclusive.

TradeApes Score

Financial Strength

31 Weak

Operating Trend

4 Stressed

Relative Value

32 Overvalued

Capital Allocation

76 Strong

Risk Management

47 Mixed

Our methods couldn't reach a reliable fair value for DXR yet.

Key Findings

What's working

+ Earnings yield 15.5% (P/E about 6.5) — inexpensive on earnings
+ About 6.6 years of cash runway at the current burn — not pressing
+ Stock-based compensation is 1% of revenue — low

What to watch

− Free-cash-flow yield -21.8% — no free cash to yield
− Free-cash-flow margin -1216% — burning cash
− Free cash flow is -1216% of revenue — the business burns cash

See every signal behind DXR's score →

AI-written analysis

The full DAXOR CORP (DXR) analysis

Why the model reads DXR as inconclusive, the methods that voted, and what would change the verdict. Written from the same filings as the score above. How these are written

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.